Breaking News, Collaborations & Alliances

Propanc, University of Jaén, Spain Enter Collaboration

For the provision of research services and scientific technical advice for the Company's POP1 drug discovery program

Propanc Biopharma, Inc. announced the execution of a research collaboration agreement with the University of Jaén, Spain, for the provision of research services and scientific technical advice for the Company’s POP1 drug discovery program.  The goal for the program is to synthesize and develop a backup clinical compound to the Company’s lead product candidate, PRP. The development of the backup compound will be used for treating patients with limited therapeutic options for the tr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters